STAT+: Allogene CEO David Chang stepping down

Allogene CEO David Chang is stepping down. WHO experts recommend an antiviral and monoclonal antibodies for the Bundibugyo Ebola outbreak. Replimune Group agreed to resubmit its melanoma drug to the FDA after prior rejections.